Federico Ponzetto, University of Turin Principal Investigator: Dr
Biomineralization: an opportunity and challenge of nanoparticle drug delivery systems for cancer therapy
Oral semaglutide appeals to needle-averse patients, but it comes with trade-offs
DOI: 10.1159/000242103 [ Links ] Meyburg J, Schulze A, Kohlmueller D, Pschl J, Linderkamp O, Hoffmann GF, et al
Do I need to follow a special diet while on GLP-1 therapy
Funding Work in the authors groups has been supported by the National Institute for Translational Neuroscience (Brazil), the Brazilian agencies Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico (CNPq) and Fundao de Amparo Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to STF and FDF), and Alzheimer Society Canada and Weston Brain Institute (to FDF)